There are two new developments in the field of eczema (atopic dermatitis). For those with milder disease, a topical medicine, Eucrisa, is now available that may help to contain the disease while limiting patients’ exposure to steroids. For those with more widespread or severe disease there is a new “biologic” medicine, Dupixent. It is given every two weeks and has shown excellent efficacy and a very good safety profile in many patients with difficult to control eczema. There is a great deal of excitement in the field of dermatology about the potential of these medicines to help us control this troubling condition. It has been over 10 years since the last new medicine was approved for eczema. Please make an appointment if you have eczema and would like to discuss these further.
Patients frequently want to know if diet plays a role in causing their acne. The honest answer is that we are still not entirely certain.
I would like try to clear up some of the controversy regarding the use of sunscreens.
Brookside Dermatology Associates is pleased to announce that Drs. Moss and Maiocco have both been selected amongst Connecticut Magazine’s 2016 Top Doctors.
With the weather turning worse these days, many people in the Northeast experience an eczema commonly referred to as “winter itch”.
Molluscum contagiosum is a common skin condition caused by a contagious virus.
Severe excessive sweating, called hyperhidrosis, can be an embarrassing and even disabling condition that affects both men and women.